Back to User profile » Prof. Dr. Mark Wilcox

Papers published by Prof. Dr. Mark Wilcox:

Original Research

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System

Torres A, Soriano A, Rivolo S, Remak E, Peral C, Kantecki M, Ansari W, Charbonneau C, Hammond J, Grau S, Wilcox M

ClinicoEconomics and Outcomes Research 2022, 14:149-161

Published Date: 18 March 2022

Review

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics

Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH

Infection and Drug Resistance 2018, 11:1959-1974

Published Date: 25 October 2018

Original Research

High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection

Monaghan TM, Negm OH, MacKenzie B, Hamed MR, Shone CC, Humphreys DP, Acharya KR, Wilcox MH

Clinical and Experimental Gastroenterology 2017, 10:169-175

Published Date: 19 July 2017

Perspectives

Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm

Crowther GS, Wilcox MH

Infection and Drug Resistance 2015, 8:333-337

Published Date: 15 September 2015